All charts and data below are CPI-U inflation-adjusted and with dividends reinvested. (Why?)
MRNA real return snapshot: after CPI-U inflation, MRNA returned +62.71% over the past year and +56.35% YTD, with dividends reinvested. Since Dec. 7, 2018, MRNA is up +92.66% in real purchasing-power return, or +9.13%/yr, and is currently −91.98% below its real total-return high on Aug. 9, 2021.
Data ending Tue Jun. 9, 2026
| Fri 2018-12-07💬 to Tue 2026-06-09 |
YTD
Return |
1 Year
Return |
||||
|---|---|---|---|---|---|---|
| MRNA × |
+56.35%
2026-06-09 |
+62.71%
2026-06-09 |
||||
| Moderna Inc NASDAQ Common Stock | ||||||
| Fri 2018-12-07💬 to Tue 2026-06-09 |
Overall
Return |
Exponential
Trendline |
||||
|---|---|---|---|---|---|---|
| MRNA × |
+92.66%
+9.13%/yr |
+0.15%/yr
(R2=0.000) |
||||
| Moderna Inc NASDAQ Common Stock | ||||||
| Fri 2018-12-07💬 to Tue 2026-06-09 |
Start
Value |
End
Value |
||||
|---|---|---|---|---|---|---|
| MRNA × |
$10,000.00
2018-12-07 |
$19,266.40
2026-06-09 |
||||
| Moderna Inc NASDAQ Common Stock | ||||||
| Year | MRNA |
|---|---|
| 2026 (YTD) | +56.35% |
| 2025 | −30.92% |
| 2024 | −59.36% |
| 2023 | −46.43% |
| 2022 | −33.57% |
| 2021 | +127.13% |
| 2020 | +426.92% |
| 2019 | +25.23% |
| 2018 | −17.70% |
| Fri 2018-12-07💬 to Tue 2026-06-09 |
Current
Drawdown |
Worst
Drawdown |
||||
|---|---|---|---|---|---|---|
| MRNA × |
−91.98%
from 2021-08-09 peak |
−96.11%
2025-11-20 from 2021-08-09 peak |
||||
| Moderna Inc NASDAQ Common Stock | ||||||
| Period ending Tue 2026-06-09 |
1
Year |
2
Years |
3
Years |
5
Years |
10
Years |
|
|---|---|---|---|---|---|---|
| MRNA × | +62.71% |
−70.41% −45.60%/yr |
−64.86% −29.43%/yr |
−82.34% −29.30%/yr |
— | |
| Moderna Inc NASDAQ Common Stock | ||||||
